Ossama Mansour: The Safety and Clinical Efficacy of Endovascular Therapy in TVAI
Ossama Mansour, Chief Executive Officer (CEO) of a Semoha University Campus, Faculty of Medicine, Alexandria University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”New paper: ‘Effectiveness and safety of endovascular therapy in patients with traumatic vertebral artery injury: A systematic review and meta-analysis.’
Traumatic vertebral artery injury (TVAI) presents a significant challenge in trauma and neurovascular care.
In this newly published systematic review and meta-analysis, our team rigorously evaluated the existing literature to determine the safety and clinical efficacy of Endovascular Therapy (EVT) for these patients.
Key highlights of our study:
- Comprehensive synthesis of current data on EVT for TVAI.
- Detailed analysis of safety profiles and clinical outcomes.
- Important insights to help guide neurosurgeons, trauma specialists, and interventionalists in complex decision-making.
A huge thank you to my co-authors and the editorial team for their hard work in bringing this research to light.”
Title: Effectiveness and safety of endovascular therapy in patients with traumatic vertebral artery injury: A systematic review and meta-analysis
Authors: Ibrahim Alnaami, Mubarak Algahtany, Ossama Yassin Mansour
Read the Full Article on Injury
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions
-
Oct 19, 2026, 13:11Giulia Furnari: Connecting With Global Hematology Experts at IACH 2026
-
Oct 19, 2026, 12:46Andrew Choong: Recognizing Thrombosis Before It Becomes Life-Threatening
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval
-
Oct 19, 2026, 10:28Brig Tathagata Chatterjee: Acute Leukemias in AYAs at the Japanese Society of Hematology Conference